Detalhe da pesquisa
1.
The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant.
Glycobiology;
34(2)2024 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38048640
2.
Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein.
J Gen Virol;
105(1)2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38271027
3.
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.
Mol Psychiatry;
28(7): 2878-2893, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36316366
4.
Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
Transfusion;
63(2): 288-293, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36573801
5.
Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2.
Environ Res;
196: 110944, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33647300
6.
CCR2 Plays a Protective Role in Rocio Virus-Induced Encephalitis by Promoting Macrophage Infiltration Into the Brain.
J Infect Dis;
219(12): 2015-2025, 2019 05 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30715407
7.
Full genome sequence of Rocio virus reveal substantial variations from the prototype Rocio virus SPH 34675 sequence.
Arch Virol;
163(1): 255-258, 2018 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28939977
8.
Establishment of a CPER reverse genetics system for Powassan virus defines attenuating NS1 glycosylation sites and an infectious NS1-GFP11 reporter virus.
mBio;
14(4): e0138823, 2023 08 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37489888
9.
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial.
EBioMedicine;
97: 104842, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37865043
10.
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology.
Nat Aging;
3(12): 1561-1575, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37957361
11.
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants.
iScience;
26(7): 107085, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37361875
12.
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern.
Vaccine;
40(34): 4929-4932, 2022 08 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35871873
13.
SARS-CoV-2 triggers complement activation through interactions with heparan sulfate.
Clin Transl Immunology;
11(8): e1413, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35999893
14.
Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems.
Pharmaceutics;
14(4)2022 Apr 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35456690
15.
The distinguishing NS5-M114V mutation in American Zika virus isolates has negligible impacts on virus replication and transmission potential.
PLoS Negl Trop Dis;
16(5): e0010426, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35536870
16.
Zika virus noncoding RNA cooperates with the viral protein NS5 to inhibit STAT1 phosphorylation and facilitate viral pathogenesis.
Sci Adv;
8(48): eadd8095, 2022 12 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36449607
17.
Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants.
Front Immunol;
13: 926262, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35757714
18.
Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern.
Vaccines (Basel);
10(4)2022 Apr 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35455326
19.
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern.
Viruses;
15(1)2022 12 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36680179
20.
Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration.
Vaccines (Basel);
10(5)2022 Apr 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35632447